Sigma Pharmaceuticals Limited

Sigma Pharmaceuticals Limited (SIP) proceeds with a deal that will slash 10 percent of its rival’s revenue. The ailing drug wholesaler is catering to Australian Pharmacy Alliance, to cut off its rival Australian Pharmaceutical Industries from its biggest customer.

Mark Hooper, the incoming chief of Sigma Pharmaceuticals Limited (SIP) has signalled that the company can survive in the industry without facing a takeover and he termed the recent tilt by Aspen Pharmacare “opportunistic”. It is to be mentioned that Mr. Hooper is currently working as the chief finance officer for Paperlinx and worked for the group from the year 2001 to 2006. Mr.

Sigma Pharmaceuticals Limited (SIP), a company with focus on manufacturing, marketing and distribution of pharmaceutical products through drugstore and grocery channels was the best performer of the week in ASX200 with a gain of 37.1 percent closing the week at 48 cents (market capitalisation $565.7 million). The company traded its stocks for 35 cents last week.

Nufarm (NUF), a company that focuses in the production and distribution of agricultural chemicals to farmers was the worst performer of the ASX100 list for the week. The company lost 7.6 percent or 55 cents to its stock price and was closed for the week at $6.63.

Nufarm (NUF), a company that concentrates in the production and distribution of agricultural chemicals to farmers was the worst performer in the ASX100 list for the week. The company lost 5.9 percent or 52 cents to its stock price and was closed for the week at $8.19.